Molecular and clinical predictors of outcome for cetuximab in non-small cell lung cancer (NSCLC): Data from the FLEX study
作者： K. J. O'Byrne , I. Bondarenko , C. Barrios , C. Eschbach , U. Martens
DOI: 10.1200/JCO.2009.27.15_SUPPL.8007
关键词:
摘要: 8007 Background: The multinational, randomized, phase III FLEX study compared cisplatin/vinorelbine (CT) plus the EGFR- antibody, cetuximab (Erbitux), with CT alone in 1st-line treatment of pat...
sci-hub.st 参考文章(0)